Bangladesh pharma market
•Download as PPTX, PDF•
0 likes•76 views
The document summarizes the top 10 global pharmaceutical companies in 2014, led by Pfizer, Novartis, and Hoffmann-La Roche. It also provides statistics on the growth of the global pharmaceutical market, which is expected to reach $1,200 billion by 2016, with generics accounting for 70% of the market outside developed countries. The highest growth is seen in Asia-Pacific countries, with emerging markets expected to account for 28% of global spending on pharmaceuticals by 2015. The document also briefly outlines the history and growth of the pharmaceutical industry in Bangladesh, which now has over 300 companies and manufactured over 5,600 medicine brands as of the time of writing.
Report
Share
Report
Share
Recommended
indian pharmaceutical industry
India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medications in the UK.
India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) is supplied by Indian pharmaceutical firms.
Pharmaceutical industry in india
The pharmaceutical industry is comprised of organizations that perform scientific research to discover and develop new drugs and market medicines for human and animal health. The industry is based on research and development of medicines that prevent or treat diseases. The Indian pharmaceutical industry is among the top 10 markets globally and generated over $20 billion in revenue last year, expected to reach $26 billion by 2016. It produces drugs for various therapeutic areas and accounts for 1.4% of the global pharmaceutical market, ranking 3rd in production volume and 13th by production size. The market is expected to grow to $55 billion by 2020. India exports drugs to over 200 countries, with the US, EU, and Africa being top importers. Major Indian companies include Sun Ph
Present Status and Scope of Pharmaceutical industry in India
The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical & Pharmaceutical Company started its maiden operation in Calcutta.
The next few decades saw the pharmaceutical industry moving through several phases, largely in accordance with government policies. The development, present status and scope of pharmaceutical industry in India.
Status of pharmaceutical industry in india
Status of Pharmaceutical Industry in India
-History
-Evolution
-Current Scenario
-Market Share
-Government Initiatives
-Top 10 Pharmaceutical Industry
-R&D Spendings
-Challenges
-Road Ahead
Growth of pharmaceutical industry
Indian pharmaceutical history began in the Gupta period from 320-550 CE, with foundational Ayurvedic texts like Charak Samhita and Sushruta Samhita. Allopathic medication was introduced during British rule but production occurred abroad until 1901, when Acharya P C Ray started the first Indian pharmaceutical company, Bangal Chemical. During World War 2, many pharmaceutical companies started in India to meet the 70% domestic demand when foreign supplies fell. India is now a major global producer and exporter of pharmaceuticals, ranking 3rd by volume, 14th by value, and 4th in generics. Its pharmaceutical exports have grown significantly each year.
Competitive landscape of the pharma industry in india
The pharmaceutical industry in India began in 1930 with the establishment of Bengal Chemicals and Pharmaceutical Works. India's pharmaceutical market has grown significantly and is expected to reach $24-34 billion by 2016. The industry is divided into several segments including finished formulations, pharmaceutical drugs, biotechnology, and equipment. Major players in the industry include Lupin, Dr. Reddy's, Cipla, and Sun Pharma. The industry supplies over 70% of India's drug demands and exports products worldwide.
Indian pharma industry 2014-15
The document summarizes the evolution of the Indian pharmaceutical industry over several phases from 1970 to the present. It began with foreign company domination and a lack of organized Indian companies. From 1970-1980 the government instituted controls over drug prices and local companies began to grow. From 1980-1990 the industry expanded domestically and internationally. From 1990-2000 research became a greater focus. Currently India has over 3000 pharmaceutical companies and aims to be a global leader in drug manufacturing due to lower costs. The industry has seen steady growth between 13-14% in recent years.
Indian pharma industry
The Indian pharmaceutical industry is emerging as a global powerhouse, becoming the third largest pharmaceutical superpower. It is considered the global pharmacy of the developing world due to its cost-competitive manufacturing capabilities. Some key facts about the industry include an annual turnover of Rs. 226 billion with a 5.2% growth rate. Major growth drivers for the industry include increasing drug R&D costs abroad, enhanced healthcare investments in developing countries, and industry dynamics like WTO patent enforcements. The industry provides opportunities in innovation, alliances, generic medicines, and embracing organizational change.
Recommended
indian pharmaceutical industry
India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medications in the UK.
India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) is supplied by Indian pharmaceutical firms.
Pharmaceutical industry in india
The pharmaceutical industry is comprised of organizations that perform scientific research to discover and develop new drugs and market medicines for human and animal health. The industry is based on research and development of medicines that prevent or treat diseases. The Indian pharmaceutical industry is among the top 10 markets globally and generated over $20 billion in revenue last year, expected to reach $26 billion by 2016. It produces drugs for various therapeutic areas and accounts for 1.4% of the global pharmaceutical market, ranking 3rd in production volume and 13th by production size. The market is expected to grow to $55 billion by 2020. India exports drugs to over 200 countries, with the US, EU, and Africa being top importers. Major Indian companies include Sun Ph
Present Status and Scope of Pharmaceutical industry in India
The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical & Pharmaceutical Company started its maiden operation in Calcutta.
The next few decades saw the pharmaceutical industry moving through several phases, largely in accordance with government policies. The development, present status and scope of pharmaceutical industry in India.
Status of pharmaceutical industry in india
Status of Pharmaceutical Industry in India
-History
-Evolution
-Current Scenario
-Market Share
-Government Initiatives
-Top 10 Pharmaceutical Industry
-R&D Spendings
-Challenges
-Road Ahead
Growth of pharmaceutical industry
Indian pharmaceutical history began in the Gupta period from 320-550 CE, with foundational Ayurvedic texts like Charak Samhita and Sushruta Samhita. Allopathic medication was introduced during British rule but production occurred abroad until 1901, when Acharya P C Ray started the first Indian pharmaceutical company, Bangal Chemical. During World War 2, many pharmaceutical companies started in India to meet the 70% domestic demand when foreign supplies fell. India is now a major global producer and exporter of pharmaceuticals, ranking 3rd by volume, 14th by value, and 4th in generics. Its pharmaceutical exports have grown significantly each year.
Competitive landscape of the pharma industry in india
The pharmaceutical industry in India began in 1930 with the establishment of Bengal Chemicals and Pharmaceutical Works. India's pharmaceutical market has grown significantly and is expected to reach $24-34 billion by 2016. The industry is divided into several segments including finished formulations, pharmaceutical drugs, biotechnology, and equipment. Major players in the industry include Lupin, Dr. Reddy's, Cipla, and Sun Pharma. The industry supplies over 70% of India's drug demands and exports products worldwide.
Indian pharma industry 2014-15
The document summarizes the evolution of the Indian pharmaceutical industry over several phases from 1970 to the present. It began with foreign company domination and a lack of organized Indian companies. From 1970-1980 the government instituted controls over drug prices and local companies began to grow. From 1980-1990 the industry expanded domestically and internationally. From 1990-2000 research became a greater focus. Currently India has over 3000 pharmaceutical companies and aims to be a global leader in drug manufacturing due to lower costs. The industry has seen steady growth between 13-14% in recent years.
Indian pharma industry
The Indian pharmaceutical industry is emerging as a global powerhouse, becoming the third largest pharmaceutical superpower. It is considered the global pharmacy of the developing world due to its cost-competitive manufacturing capabilities. Some key facts about the industry include an annual turnover of Rs. 226 billion with a 5.2% growth rate. Major growth drivers for the industry include increasing drug R&D costs abroad, enhanced healthcare investments in developing countries, and industry dynamics like WTO patent enforcements. The industry provides opportunities in innovation, alliances, generic medicines, and embracing organizational change.
pharma industry ppt
The Indian pharmaceutical industry is the third largest in terms of volume and has grown significantly in recent years. It has a large number of manufacturing plants and is a major exporter of generic drugs. However, it also faces challenges from stringent regulation in some markets and increasing competition from other low-cost producers. The industry is dominated by small and medium enterprises and has grown at a fast pace due to the low costs of production and skilled workforce in India.
Indian pharmaceutical industry
I have to try to share some knowledge about the Indian health care sector. I have put some data to get more and more knowledge which can easily understand.
Future of the Global Pharmaceutical Industry
The global pharmaceutical industry is much larger than previously estimated and is projected to nearly triple in size by 2060. Torreya Partners estimates the current size of the global pharma sector to be $1.13 trillion based on their analysis of over 30,000 companies, which is 30% larger than other recent estimates. Their data indicates the industry is dominated by 17 large global companies that make up 45% of the value, with specialty pharma, China, generics, and Japan also representing significant portions of the total industry value. The pharmaceutical sector is one of the largest global industries and is projected to continue growing rapidly due to expanding global wealth and increasing healthcare spending.
Brief Report on the Indian Pharmaceutical Industry - 2011
The document summarizes the pharmaceutical industry in India. It provides an overview of the industry, noting that it is highly fragmented with over 20,000 registered units and is a $4.5 billion industry growing annually by 8-9%. It also profiles some of the largest pharmaceutical companies in India, including Ranbaxy, Dr. Reddy's Laboratories, and Cipla, and discusses their operations, market shares, and R&D investments. The industry is a major exporter of generic drugs and has a competitive advantage due to its skilled workforce and cost-effective production capabilities.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
How Many Pharma Companies in India?
This document provides a directory of pharmaceutical manufacturing units in India for the year 2007. It lists pharmaceutical manufacturers from across India, divided by state. For Andhra Pradesh, it lists 60 formulation manufacturing units, providing information such as company name, address, telephone number, and email/website when available. The units are listed alphabetically by company name within the Andhra Pradesh section. It also notes that the directory contains information for 10563 total pharmaceutical manufacturers in India divided into formulation and bulk drug manufacturers.
Indian pharmaceutical industry
The Indian pharmaceutical industry is the third largest by volume and fourteenth largest by value. It supplies affordable drugs domestically while also exporting $10 billion in generic medicines annually. Key strengths include low production costs, a skilled workforce, and strong manufacturing capabilities. However, the industry also faces challenges like low R&D investment, regulatory issues, and international trade barriers that could hamper further growth.
Indian pharmaceutical industry By Big Pharma Jobs
The Indian pharmaceutical industry has grown substantially over the past few decades and is expected to continue growing. It has expanded from $0.3 billion in 1980 to $12 billion currently, and is projected to reach $1.5 trillion globally by 2020. The industry faces issues such as patent cliffs wiping out revenues, high R&D costs, and increasing regulatory pressures. However, India has a large, fragmented industry with low-cost production, a dominant position in generic drugs, and is a major exporter and provider of affordable medicines to its population and globally. Key local and international players operate in the growing Indian market.
Prospect of Pharmaceutical Industry
The pharmaceutical industry in Bangladesh has grown considerably in recent decades and is poised to continue expanding. With a current market size of $1.2 billion, the market is projected to reach $2 billion by 2018. Several factors contribute to the positive prospects for the pharmaceutical industry, including growing health awareness among an increasingly educated population, companies gaining FDA approval to export to the US, and expanding domestic production of active pharmaceutical ingredients. The industry is also diversifying into biotechnology and medical devices. With continued government support, a focus on new export markets, and addressing infrastructure needs, the pharmaceutical sector in Bangladesh is well-positioned for further growth in 2018 and beyond.
Growth of Indian pharmaceutical industry
This document is a research paper on the growth of the Indian pharmaceutical industry submitted by Sanjay Trivedi for his MBA program. It includes a declaration that the research is based on secondary sources. The introduction provides an overview of the global pharmaceutical industry and outlines that the Indian pharmaceutical industry has grown to $19 billion. It describes the structure of the Indian pharmaceutical sector and the main triggers and actors that have driven innovation in the industry. It also analyzes the nature of innovation and different firm groups in the Indian pharmaceutical sector, categorizing firms based on their annual sales, exports, R&D investments, and innovative activities.
Pharmaceutical industry-in-india
The Indian pharmaceutical industry is highly fragmented with over 20,000 registered units and is expected to grow at a CAGR of 23.9% to reach $55 billion by 2020. Major players include Cipla, Ranbaxy Laboratories, Dr. Reddy's Laboratories, Sun Pharma, and Lupin. The industry benefits from a large pool of skilled labor, low costs, and a growing middle class in India. Exports of pharmaceutical products have increased at 26.1% CAGR between 2006-2013. The industry faces price controls and competition but continues to grow through generic drugs, clinical trials, and an expanding domestic market.
indian Pharmaceutical industry export import overview
Pharmaceutical Industry-EXPORT IMPORT INDIA
The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices
Industry analysis pharma
The document provides an overview of the Indian pharmaceutical industry. It discusses the evolution of the industry through 5 phases from the early years to the current focus on innovation and research. Key points covered include the major players in the industry, drug trials conducted in India, medical tourism, moving up the value chain through generics and APIs, important pharmaceutical associations, and the future potential for growth in the retail segment and clinical trials outsourcing.
Indian Pharmaceutical Industry
The document discusses the Indian pharmaceutical industry. It notes that expenditure on pharmaceuticals as a percentage of total healthcare spending is expected to increase significantly from 28% in 2007 to over 40% by 2015. This rapid growth will be driven by factors on both the supply and demand side. On the supply side, India has a strong competitive advantage in terms of low production costs. On the demand side, factors such as rising incomes, expansion of health insurance coverage, and a growing disease burden are expected to boost pharmaceutical consumption in India. The Indian pharmaceutical industry is well-positioned for continued strong growth over the coming years.
Pharmaexport
The document discusses India's pharmaceutical exports and the Pharmaceutical Export Promotion Council of India (Pharmexcil). It notes that India is a major global manufacturer and exporter of pharmaceuticals, exporting to over 200 countries. Pharmexcil is the government agency that promotes pharmaceutical exports and organizes trade delegations and meetings. The top importer of Indian pharmaceuticals is the US, accounting for 25% of exports. Exports have grown in recent years and India aims to further increase its share of global pharmaceutical exports.
Pharmaceutical Industry Analysis
India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. India produces 40-70 per cent of the WHO demand for DPT & BCG and 90 per cent of measles vaccine. Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation, Doctors without Borders, the UNCTAD etc.
Changing trends in Indian Pharmaceutical Industry
The document summarizes the evolution of the Indian pharmaceutical industry through five phases from the pre-1970s to the present. It began with foreign company domination and a lack of organized Indian companies (Phase I). The government then gained control and capped drug prices, allowing local companies to emerge (Phase II). Indian companies then focused on bulk drug manufacturing and exports (Phase III) before experiencing rapid domestic and international market expansion (Phase IV). The industry is now focused on innovation, research, and adapting to changing patent laws (Phase V). The document also outlines India's competitive advantages in low-cost, high-quality drug production and its significant cost advantages over the US. It discusses the impact of TRIPS and new drug pricing policies on
Indian Pharma Industry
The document discusses the Indian pharmaceutical industry. It provides an overview of major players, the Indian and global scenarios, future outlook, and areas for boosting competitiveness. The industry has grown significantly over time and India is now a top producer and exporter of generic drugs globally. The outlook remains positive with the market expected to reach $74 billion by 2020 and become one of the top ten markets worldwide. However, further investment in R&D and addressing regulatory issues can help strengthen the industry.
Pharmaceutical Sector Report July 2017
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical sector accounts for about 2.4% of the global pharmaceutical industry in value and is expected to grow at a CAGR of 12.89% to reach $55 billion by 2020.
- India accounts for 20% of global exports in generics drugs. Exports were $16.4 billion in 2016-17 and are expected to grow 30% to $20 billion by 2020.
- Generic drugs form the largest segment of the Indian pharmaceutical market, accounting for 70% of the market. Anti-infectives represent the largest therapeutic segment.
The document discusses India's advantages in low-
Phamaceutical sector in india
This ppt gives an overview of the Indian Pharmaceutical sector. We have concentrated on 5 aspects of the sector and analysed it. The covered heads are history, business model, Marketing, Competitor analysis, Financials and Trends.
Pharmaceutical industry in bangladesh(assigment)...n iloy
The document discusses the pharmaceutical sector in Bangladesh. It provides background on the history and growth of the pharmaceutical industry in Bangladesh. Key points include:
- The pharmaceutical sector has grown significantly since the 1980s and is now a major contributor to Bangladesh's economy. It supplies 97% of domestic medicine needs.
- The industry is highly regulated by bodies like the Directorate General of Drug Administration. The National Drug Policy of 1982 helped foster growth by promoting local production and restricting imports.
- Major local companies include Square Pharmaceuticals, Incepta Pharma, Beximco Pharma, and ACME Laboratories. The industry also includes some multinational companies.
- In 2012, Square Pharma
Analysis of the Pharmaceutical Industry
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
More Related Content
What's hot
pharma industry ppt
The Indian pharmaceutical industry is the third largest in terms of volume and has grown significantly in recent years. It has a large number of manufacturing plants and is a major exporter of generic drugs. However, it also faces challenges from stringent regulation in some markets and increasing competition from other low-cost producers. The industry is dominated by small and medium enterprises and has grown at a fast pace due to the low costs of production and skilled workforce in India.
Indian pharmaceutical industry
I have to try to share some knowledge about the Indian health care sector. I have put some data to get more and more knowledge which can easily understand.
Future of the Global Pharmaceutical Industry
The global pharmaceutical industry is much larger than previously estimated and is projected to nearly triple in size by 2060. Torreya Partners estimates the current size of the global pharma sector to be $1.13 trillion based on their analysis of over 30,000 companies, which is 30% larger than other recent estimates. Their data indicates the industry is dominated by 17 large global companies that make up 45% of the value, with specialty pharma, China, generics, and Japan also representing significant portions of the total industry value. The pharmaceutical sector is one of the largest global industries and is projected to continue growing rapidly due to expanding global wealth and increasing healthcare spending.
Brief Report on the Indian Pharmaceutical Industry - 2011
The document summarizes the pharmaceutical industry in India. It provides an overview of the industry, noting that it is highly fragmented with over 20,000 registered units and is a $4.5 billion industry growing annually by 8-9%. It also profiles some of the largest pharmaceutical companies in India, including Ranbaxy, Dr. Reddy's Laboratories, and Cipla, and discusses their operations, market shares, and R&D investments. The industry is a major exporter of generic drugs and has a competitive advantage due to its skilled workforce and cost-effective production capabilities.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
How Many Pharma Companies in India?
This document provides a directory of pharmaceutical manufacturing units in India for the year 2007. It lists pharmaceutical manufacturers from across India, divided by state. For Andhra Pradesh, it lists 60 formulation manufacturing units, providing information such as company name, address, telephone number, and email/website when available. The units are listed alphabetically by company name within the Andhra Pradesh section. It also notes that the directory contains information for 10563 total pharmaceutical manufacturers in India divided into formulation and bulk drug manufacturers.
Indian pharmaceutical industry
The Indian pharmaceutical industry is the third largest by volume and fourteenth largest by value. It supplies affordable drugs domestically while also exporting $10 billion in generic medicines annually. Key strengths include low production costs, a skilled workforce, and strong manufacturing capabilities. However, the industry also faces challenges like low R&D investment, regulatory issues, and international trade barriers that could hamper further growth.
Indian pharmaceutical industry By Big Pharma Jobs
The Indian pharmaceutical industry has grown substantially over the past few decades and is expected to continue growing. It has expanded from $0.3 billion in 1980 to $12 billion currently, and is projected to reach $1.5 trillion globally by 2020. The industry faces issues such as patent cliffs wiping out revenues, high R&D costs, and increasing regulatory pressures. However, India has a large, fragmented industry with low-cost production, a dominant position in generic drugs, and is a major exporter and provider of affordable medicines to its population and globally. Key local and international players operate in the growing Indian market.
Prospect of Pharmaceutical Industry
The pharmaceutical industry in Bangladesh has grown considerably in recent decades and is poised to continue expanding. With a current market size of $1.2 billion, the market is projected to reach $2 billion by 2018. Several factors contribute to the positive prospects for the pharmaceutical industry, including growing health awareness among an increasingly educated population, companies gaining FDA approval to export to the US, and expanding domestic production of active pharmaceutical ingredients. The industry is also diversifying into biotechnology and medical devices. With continued government support, a focus on new export markets, and addressing infrastructure needs, the pharmaceutical sector in Bangladesh is well-positioned for further growth in 2018 and beyond.
Growth of Indian pharmaceutical industry
This document is a research paper on the growth of the Indian pharmaceutical industry submitted by Sanjay Trivedi for his MBA program. It includes a declaration that the research is based on secondary sources. The introduction provides an overview of the global pharmaceutical industry and outlines that the Indian pharmaceutical industry has grown to $19 billion. It describes the structure of the Indian pharmaceutical sector and the main triggers and actors that have driven innovation in the industry. It also analyzes the nature of innovation and different firm groups in the Indian pharmaceutical sector, categorizing firms based on their annual sales, exports, R&D investments, and innovative activities.
Pharmaceutical industry-in-india
The Indian pharmaceutical industry is highly fragmented with over 20,000 registered units and is expected to grow at a CAGR of 23.9% to reach $55 billion by 2020. Major players include Cipla, Ranbaxy Laboratories, Dr. Reddy's Laboratories, Sun Pharma, and Lupin. The industry benefits from a large pool of skilled labor, low costs, and a growing middle class in India. Exports of pharmaceutical products have increased at 26.1% CAGR between 2006-2013. The industry faces price controls and competition but continues to grow through generic drugs, clinical trials, and an expanding domestic market.
indian Pharmaceutical industry export import overview
Pharmaceutical Industry-EXPORT IMPORT INDIA
The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices
Industry analysis pharma
The document provides an overview of the Indian pharmaceutical industry. It discusses the evolution of the industry through 5 phases from the early years to the current focus on innovation and research. Key points covered include the major players in the industry, drug trials conducted in India, medical tourism, moving up the value chain through generics and APIs, important pharmaceutical associations, and the future potential for growth in the retail segment and clinical trials outsourcing.
Indian Pharmaceutical Industry
The document discusses the Indian pharmaceutical industry. It notes that expenditure on pharmaceuticals as a percentage of total healthcare spending is expected to increase significantly from 28% in 2007 to over 40% by 2015. This rapid growth will be driven by factors on both the supply and demand side. On the supply side, India has a strong competitive advantage in terms of low production costs. On the demand side, factors such as rising incomes, expansion of health insurance coverage, and a growing disease burden are expected to boost pharmaceutical consumption in India. The Indian pharmaceutical industry is well-positioned for continued strong growth over the coming years.
Pharmaexport
The document discusses India's pharmaceutical exports and the Pharmaceutical Export Promotion Council of India (Pharmexcil). It notes that India is a major global manufacturer and exporter of pharmaceuticals, exporting to over 200 countries. Pharmexcil is the government agency that promotes pharmaceutical exports and organizes trade delegations and meetings. The top importer of Indian pharmaceuticals is the US, accounting for 25% of exports. Exports have grown in recent years and India aims to further increase its share of global pharmaceutical exports.
Pharmaceutical Industry Analysis
India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. India produces 40-70 per cent of the WHO demand for DPT & BCG and 90 per cent of measles vaccine. Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation, Doctors without Borders, the UNCTAD etc.
Changing trends in Indian Pharmaceutical Industry
The document summarizes the evolution of the Indian pharmaceutical industry through five phases from the pre-1970s to the present. It began with foreign company domination and a lack of organized Indian companies (Phase I). The government then gained control and capped drug prices, allowing local companies to emerge (Phase II). Indian companies then focused on bulk drug manufacturing and exports (Phase III) before experiencing rapid domestic and international market expansion (Phase IV). The industry is now focused on innovation, research, and adapting to changing patent laws (Phase V). The document also outlines India's competitive advantages in low-cost, high-quality drug production and its significant cost advantages over the US. It discusses the impact of TRIPS and new drug pricing policies on
Indian Pharma Industry
The document discusses the Indian pharmaceutical industry. It provides an overview of major players, the Indian and global scenarios, future outlook, and areas for boosting competitiveness. The industry has grown significantly over time and India is now a top producer and exporter of generic drugs globally. The outlook remains positive with the market expected to reach $74 billion by 2020 and become one of the top ten markets worldwide. However, further investment in R&D and addressing regulatory issues can help strengthen the industry.
Pharmaceutical Sector Report July 2017
The document provides an overview of the pharmaceutical industry in India. Some key points:
- The Indian pharmaceutical sector accounts for about 2.4% of the global pharmaceutical industry in value and is expected to grow at a CAGR of 12.89% to reach $55 billion by 2020.
- India accounts for 20% of global exports in generics drugs. Exports were $16.4 billion in 2016-17 and are expected to grow 30% to $20 billion by 2020.
- Generic drugs form the largest segment of the Indian pharmaceutical market, accounting for 70% of the market. Anti-infectives represent the largest therapeutic segment.
The document discusses India's advantages in low-
Phamaceutical sector in india
This ppt gives an overview of the Indian Pharmaceutical sector. We have concentrated on 5 aspects of the sector and analysed it. The covered heads are history, business model, Marketing, Competitor analysis, Financials and Trends.
What's hot (20)
Brief Report on the Indian Pharmaceutical Industry - 2011
Brief Report on the Indian Pharmaceutical Industry - 2011
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overview
Similar to Bangladesh pharma market
Pharmaceutical industry in bangladesh(assigment)...n iloy
The document discusses the pharmaceutical sector in Bangladesh. It provides background on the history and growth of the pharmaceutical industry in Bangladesh. Key points include:
- The pharmaceutical sector has grown significantly since the 1980s and is now a major contributor to Bangladesh's economy. It supplies 97% of domestic medicine needs.
- The industry is highly regulated by bodies like the Directorate General of Drug Administration. The National Drug Policy of 1982 helped foster growth by promoting local production and restricting imports.
- Major local companies include Square Pharmaceuticals, Incepta Pharma, Beximco Pharma, and ACME Laboratories. The industry also includes some multinational companies.
- In 2012, Square Pharma
Analysis of the Pharmaceutical Industry
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Financial Management in Pharmaceutical industry
The report was prepared with the overview of global pharmaceutical markets and Asian markets with special emphasis on emerging markets such as India.
PHR5108-Part-5-Drug Policy 2016-June-2021 (1).ppt
This document summarizes key points of Bangladesh's third National Drug Policy passed in 2016. The policy aims to regulate the country's large pharmaceutical sector to benefit both industry and public health. Major points include making Good Manufacturing Practice mandatory, controlling counterfeit drugs, compensating for harmful effects, regulating herbal and traditional medicines, promoting exports, allowing foreign investment, and updating essential drug lists. The policy seeks to continue developing Bangladesh's pharmaceutical industry while also improving access to affordable, quality medicines.
Export potentiality of pharmaceutical goods in Bangladesh
The document provides an overview of Bangladesh's growing pharmaceutical sector and its export potential. It discusses that Bangladesh's pharmaceutical exports have increased significantly in recent years from $8.2 million in 2004 to $43.63 million in 2013. Bangladeshi pharmaceutical companies now meet 97% of domestic demand and are expanding exports to over 72 countries in Asia, Africa, Europe and Latin America. While the sector has potential for further growth, it still faces barriers such as a lack of facilities for bioequivalency tests that adds costs.
Pharmaceutical industries in bangladesh
The pharmaceutical industry in Bangladesh has grown significantly since the 1950s and is now the second largest contributor to the country's economy. There are over 230 pharmaceutical companies in Bangladesh that produce around 97% of the drugs used domestically. The industry has grown at a fast pace, with the market size reaching 30 billion taka annually and exports now going to 79 different countries. However, to realize its full potential, the industry still needs more investment in research and development facilities as well as incentives for exporting active pharmaceutical ingredients.
Pharmaceutical industry in india
The pharmaceutical industry in India is the third largest in the world by volume. It has grown significantly since the 1960s and now holds a market share of $14 billion in the US. Exports of pharmaceutical products from India have grown at a compound annual rate of 21.25% between 2006-07 and 2008-09. Ranbaxy Laboratories is a major Indian pharmaceutical company with global sales of over $1 billion in 2006. It has manufacturing facilities in several countries and markets drugs in over 125 countries. The Indian pharmaceutical industry is poised for continued growth and increasing global market share in the coming years.
Overview of the Pharma industry
The Indian pharmaceutical industry has grown tremendously over the past few decades from being almost non-existent to meeting nearly 95% of the country's pharmaceutical needs. It is now self-reliant in terms of production capabilities across a wide range of medicines. The industry is highly fragmented with over 20,000 registered units and is characterized by intense price competition and government price controls. Exports have also increased significantly and are expected to surpass domestic sales in the coming years, driven primarily by growth in formulation exports. India also has the most FDA-approved manufacturing facilities outside of the US, positioning it as an important supplier for the global pharmaceutical market.
Growth of indian pharmaceuticals in the world market
The document provides an overview of the growth of the Indian pharmaceutical industry. It discusses factors that have contributed to the industry's growth, including low production costs, contract manufacturing, and research and development. It also outlines government policies that have supported the industry and notes that the industry is moving towards basic research and exporting generic drugs to markets like the US. While the industry was previously focused on domestic needs, exports now drive much of its growth. The transition to a new patent regime allowing product patents brings both opportunities and challenges to the evolving Indian pharmaceutical sector.
PROBLEMS AND PROSPECTS PHARMA PRODUCT SELLING..
The document summarizes the pharmaceutical industry in India. It notes that India has over 24,000 licensed pharmaceutical companies and is among the top 35 drug producers worldwide. The industry has grown significantly in recent decades from repackaging drugs to manufacturing many bulk drugs and generics. It is estimated the market will reach $40.18 billion by 2014 and $70.60 billion by 2019. While the industry faces some challenges like drug price controls, it is poised for continued growth due to factors like rising incomes, expansion in rural areas, and improvements in healthcare infrastructure.
National and international status of pharma indus.
The document summarizes the status of the global and Indian pharmaceutical industries. It notes that the global pharmaceutical market is expected to reach $1.18 trillion by 2024, driven by aging populations and chronic disease growth. The top companies globally in 2024 are predicted to be Pfizer, Novartis, and Roche. Oncology is the largest area of R&D spending. In India, the market was worth $18.12 billion in 2018 and is expected to grow to $55 billion by 2020. India supplies over 50% of global generic demand and has strong advantages in low-cost production. The top publicly listed Indian pharmaceutical companies are Sun Pharma, Dr. Reddy's, Cipla, Aurobind
MTBiz January 2017
MTBiz is for you if you are looking for contemporary information on business, economy and especially on banking industry of Bangladesh. You would also find periodical information on Global Economy and Commodity Markets.
Bio10PharmaIndiaInternational
Bio10 Pharma is a licensed pharmaceutical distributor based in Guwahati, India. The company's objective is to market and supply pharmaceutical products and services to hospitals, government institutions, healthcare professionals, and retailers. Its goals include creating a widespread supply network, establishing long-term client relationships, maintaining quality, and improving accessibility of medicines in remote areas. The company offers a wide range of medical supplies and drugs, dealing with premium brands. It aims to contribute to improving public health in the region through its work.
Pharma industry 1-4_9_29_50
The document provides an overview of the Indian pharmaceutical industry, including its history, growth, market structure, competition, exports and imports, and the effects of foreign investment. Some key points:
- The industry has grown significantly since its early years and now accounts for 8% of global pharmaceutical production.
- Major players include Ranbaxy, Dr. Reddy's Laboratories, Sun Pharmaceuticals, and AurobindoPharma.
- Exports have shown strong growth and now contribute around half of revenue for top companies. The US and Europe are major export markets.
- Foreign investment has impacted areas like new drug development, manufacturing standards, and marketing skills. Mauritius is a significant source of foreign
winter project
The pharmaceutical industry is the world's largest industry worth $2.8 trillion globally. The Indian pharmaceutical industry is the third largest by volume and exports 20% of generic drugs worldwide. It has grown significantly over the past two decades and is expected to become the sixth largest pharmaceutical market globally, worth $55 billion by 2020. The industry faces challenges of being highly fragmented, low profit margins due to government price controls, and low research and development investments due to pricing norms. The government is taking initiatives to support the industry through funding and reforms.
Pharmaceuticals Sector Report - April 2018
The document provides an overview of the pharmaceutical industry in India. Some key points:
1. The Indian pharmaceutical industry is expected to grow to $100 billion by 2025 from $27.57 billion in 2016, expanding at a CAGR of 12.89% between 2015-2020.
2. India accounts for 20% of global exports in generics drugs, with exports standing at $16.84 billion in 2016-17 and projected to reach $20 billion by 2020.
3. The domestic generics drugs market was valued at $26.1 billion in 2016 and has significant potential for further growth.
Nikroxx file pdf
This document is a dissertation report submitted by Nikhil Jhamb to Kurukshetra University in partial fulfillment of an MBA degree. The report analyzes the management information system reports of 10 pharmaceutical companies in Paonta Sahib, India. It includes an introduction on the pharmaceutical industry in India, profiles of the 10 companies studied, a chapter on management information systems, the research methodology used, an analysis and interpretation of data from the companies' MIS reports, findings from the study, and recommendations and conclusions. The key points provided on the pharmaceutical industry in India note that supply is higher for traditional therapeutic segments typical of a developing market, while demand is very high for certain therapeutic segments and will change as life expectancy and literacy
Nikroxx file pdf
This document is a dissertation report submitted by Nikhil Jhamb to Kurukshetra University in partial fulfillment of an MBA degree. The report analyzes the management information system reports of 10 pharmaceutical companies in Paonta Sahib, India. It includes an introduction to the Indian pharmaceutical industry, profiles of the 10 companies studied, a description of the research methodology used, an analysis and interpretation of data from the companies' MIS reports, findings from the study, and recommendations and conclusions. The Indian pharmaceutical industry is a $4.5 billion industry that is highly fragmented across more than 20,000 registered units and is an important industry in India.
Pharmaceuticals Sector Report - April 2019
The document provides an overview of the pharmaceutical industry in India. Some key points:
- India supplies over 50% of global demand for various vaccines and 40% of generic drugs in the US. The pharmaceutical sector was valued at $33 billion in 2017.
- Exports have grown significantly, reaching $17.27 billion in FY2018. The domestic market is also growing rapidly and is expected to reach $27.9 billion by 2020.
- Growth is driven by low production costs, a large skilled workforce, increasing healthcare spending, and a large generics market. The government is also supporting industry growth through initiatives like increasing FDI limits.
Economic and sectoral impact of covid pandemic
Presentation studies the Impact of COVID on Different Sectors of Indian Stock Market. Article observes significant changes in Indian Industrial Sectors in the wake of COVID 19 Pandemic.
Similar to Bangladesh pharma market (20)
Pharmaceutical industry in bangladesh(assigment)...n iloy
Pharmaceutical industry in bangladesh(assigment)...n iloy
Export potentiality of pharmaceutical goods in Bangladesh
Export potentiality of pharmaceutical goods in Bangladesh
Growth of indian pharmaceuticals in the world market
Growth of indian pharmaceuticals in the world market
National and international status of pharma indus.
National and international status of pharma indus.
More from Biplob Sarker
Coronavirus (covid19)
The document discusses Coronavirus (COVID-19). It states that COVID-19 is caused by a new coronavirus that emerged in China in late 2019. Symptoms include cough, fever and shortness of breath. While most cases are mild, some can be severe or even cause death. The virus can be transmitted between people. There is currently no vaccine, so prevention focuses on hand washing, coughing etiquette, and self-isolation when sick.
Mupirocin
This presentation discusses Mupirocin 2% ointment for treating bacterial skin infections like impetigo. Impetigo is a common skin infection in children caused by Staphylococcus or Streptococcus bacteria. It starts as skin lesions that may fill with pus or fluid. Mupirocin 2% ointment works by inhibiting bacterial protein and RNA synthesis. It is applied 3 times daily for up to 10 days to treat impetigo caused by Staphylococcus aureus and Streptococcus pyogenes. The ointment offers localized treatment with fewer side effects than oral antibiotics.
World leading pharmaceutical company
This document lists the top 50 pharmaceutical companies in the world along with their headquarters. The top 5 companies are Pfizer based in New York, NY, GlaxoSmithKline in London, England, Sanofi-Aventis in Paris, France, Novartis in Basel, Switzerland, and AstraZeneca in London, England. The document provides the names and headquarters locations of numerous other major pharmaceutical companies.
Baclofen
This presentation discusses the skeletal muscle relaxant Baclofen and the Medicon product Balo-10 tablets. Baclofen works by inhibiting spinal reflexes and enhancing the inhibitory neurotransmitters GABA and glycine. It is indicated for treating conditions caused by muscle spasms like spasticity, back pain, and headaches. Balo-10 is a 10mg tablet that follows a titration schedule for administration. Its benefits include effectiveness, safety for long term use, and minimal side effects. The presentation provides information on Balo-10's competitors, sales and prescription targets, and objectives to make it a leading brand.
Omeprazole injection
Omeprazole injection is used to suppress gastric acid hypersecretion. It works by inhibiting the proton pump in the stomach. It is indicated for acute gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome, and preventing acid aspiration where oral medication is not appropriate. For ulcers and reflux esophagitis, the recommended dose is 40 mg once daily. For Zollinger-Ellison syndrome, the initial dose is 60 mg daily and may be increased or divided into twice daily dosing. It is also recommended at 40 mg 1 hour before surgery for acid aspiration prophylaxis.
Linagliptin
This presentation discusses the drug Linagliptin. It works by selectively inhibiting the DPP-4 enzyme, which helps increase levels of incretin hormones GLP-1 and GIP. This improves glucose regulation by increasing insulin secretion and lowering glucagon secretion in response to blood glucose levels. Linagliptin is indicated for use as both monotherapy and combination therapy with other drugs like metformin or sulfonylureas to control blood sugar levels in type 2 diabetes. The recommended dosage is 5mg once daily, with or without food. The drug offers effective control of A1C with a low risk of hypoglycemia and no weight gain. It is targeted towards several types of doctors including diabetologists and endocr
More from Biplob Sarker (6)
Recently uploaded
From Hope to Despair The Top 10 Reasons Businesses Ditch SEO Tactics.pptx
From Hope to Despair: The Top 10 Reasons Businesses Ditch SEO Tactics
Are you tired of seeing your business's online visibility plummet from hope to despair? When it comes to SEO tactics, many businesses find themselves grappling with challenges that lead them to abandon their strategies altogether. In a digital landscape that's constantly evolving, staying on top of SEO best practices is crucial to maintaining a competitive edge.
In this blog, we delve deep into the top 10 reasons why businesses ditch SEO tactics, uncovering the pain points that may resonate with you:
1. Algorithm Changes: The ever-changing algorithms can leave businesses feeling like they're chasing a moving target. Search engines like Google frequently update their algorithms to improve user experience and provide more relevant search results. However, these updates can significantly impact your website's visibility and ranking if you're not prepared.
2. Lack of Results: Investing time and resources without seeing tangible results can be disheartening. The absence of immediate results often leads businesses to lose faith in their SEO strategies. It's important to remember that SEO is a long-term game that requires patience and consistent effort.
3. Technical Challenges: From site speed issues to complex metadata implementation, technical hurdles can be daunting. Overcoming these challenges is crucial for SEO success, as technical issues can hinder your website's performance and user experience.
4. Keyword Competition: Fierce competition for top keywords can make it hard to rank effectively. Businesses often struggle to find the right balance between targeting high-traffic keywords and finding less competitive, niche keywords that can still drive significant traffic.
5. Lack of Understanding of SEO Basics: Many businesses dive into the complex world of SEO without fully grasping the fundamental principles. This lack of understanding can lead to several issues:
Keyword Awareness: Failing to recognize the importance of keyword research and targeting the right keywords in content.
On-Page Optimization: Ignorance regarding crucial on-page elements such as meta tags, headers, and content structure.
Technical SEO Best Practices: Overlooking essential aspects like site speed, mobile responsiveness, and crawlability.
Backlinks: Not understanding the value of high-quality backlinks from reputable sources.
Analytics: Failing to track and analyze data prevents businesses from optimizing their SEO efforts effectively.
6. Unrealistic Expectations and Timeframe: Entrepreneurs often fall prey to the allure of quick fixes and overnight success. Unrealistic expectations can overshadow the reality of the time and effort needed to see tangible results in the highly competitive digital landscape. SEO is a long-term strategy, and setting realistic goals is crucial for success.
#SEO #DigitalMarketing #BusinessGrowth #OnlineVisibility #SEOChallenges #BostonSEO
How to Kickstart Content Marketing With A Small Team - Dennis Shiao
How to Kickstart Content Marketing With A Small Team - Dennis ShiaoDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Can you kickstart content marketing when you have a small team or even a team of one? Why yes, you can! Dennis Shiao, founder of marketing agency Attention Retention will detail how to draw insights from subject matter experts (SMEs) and turn them into articles, bylines, blog posts, social media posts and more. He’ll also share tips on content licensing and how to establish a webinar program. Attend this session to learn how to make an impact with content marketing even when you have a small team and limited resources.
Key Takeaways:
- You don't need a large team to start a content marketing program
- A webinar program yields a "one-to-many" approach to content creation
- Use partnerships and licensing to create new content assetsHow to Make Your Trade Show Booth Stand Out
Unlock the secrets to creating a standout trade show booth with our comprehensive guide from Blue Atlas Marketing! This presentation is packed with essential tips and innovative strategies to ensure your booth attracts attention, engages visitors, and drives business success. Whether you're a seasoned exhibitor or a first-timer, these expert insights will help you maximize your impact and make a memorable impression in a crowded exhibition hall. Learn how to:
Design an eye-catching and inviting booth
Incorporate interactive elements that engage visitors
Use effective branding and visuals to reinforce your message
Plan your booth layout for maximum traffic flow
Implement technology to enhance the visitor experience
Create memorable experiences that leave a lasting impression
Transform your trade show presence with these proven tactics and ensure your booth stands out from the competition. Download the PDF now and start planning your next successful exhibit!
Advanced Storytelling Concepts for Marketers
Every marketer knows you’re supposed to tell a story, but do you know how to tell a story? Do you know why you’re supposed to tell a story? Do you even truly know what a story is? While many marketing presentations emphasize the value of mythic storytelling, the nuts and bolts of actually constructing a story are never explored.
The goal of marketing may be to achieve specific KPIs that drive sales, which is very objective, but the top of the marketing funnel requires a softer approach. In our data-driven results-oriented fast-paced world, marketers must quantify results, but those results will never be achieved unless prospects are first approached with humanity.
There is a common misunderstanding that the so-called “soft skills” of marketing such as language and art are unmeasurable and subjective, but while the objective measures of market research are merely 100 years old, the rules of aesthetics have been perfected over the last 2,500 years.
Great story construction is a skill that requires significant knowledge and practice. This presentation will be a review of the ancient art of story construction.
We will discuss:
• Rhetoric – The art of effective communication
• The Socratic Method – You cannot teach, but you can persuade people to learn
• Plato’s Cave – You sell products, but you market ideas
• Aristotle’s Six Dramatic Elements – The secret recipe for marketing stories
This is for senior marketers who are tasked with creating effective narratives or guiding others in the process. By the end of the session, attendees will have gained the knowledge needed to work storytelling into all phases of the buyer’s journey.
SEO in the AI Era - Trust, Quality and Content Discovery - Andy Crestodina
SEO in the AI Era - Trust, Quality and Content Discovery - Andy CrestodinaDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
We’ve entered a new era in digital. Search and AI are colliding, in more ways than one. And they all have major implications for marketers.
• SEOs now use AI to optimize content.
• Google now uses AI to generate answers.
• Users are skipping search completely. They can now use AI to get answers. So AI has changed everything …or maybe not. Our audience hasn’t changed. Their information needs haven’t changed. Their perception of quality hasn’t changed. In reality, the most important things haven’t changed at all. In this session, you’ll learn the impact of AI. And you’ll learn ways that AI can make us better at the classic challenges: getting discovered, connecting through content and staying top of mind with the people who matter most. We’ll use timely tools to rebuild timeless foundations. We’ll do better basics, but with the most advanced techniques. Andy will share a set of frameworks, prompts and techniques for better digital basics, using the latest tools of today. And in the end, Andy will consider - in a brief glimpse - what might be the biggest change of all, and how to expand your footprint in the new digital landscape.
Key Takeaways:
How to use AI to optimize your content
How to find topics that algorithms love
How to get AI to mention your content and your brandPickUp_conversational AI_Capex, Inc._20240610
PickUp, Improve conversions with scenario-based conversational AI.
How to Start Affiliate Marketing with ChatGPT- A Step-by-Step Guide (1).pdf
Discover the power of affiliate marketing with ChatGPT! This comprehensive guide takes you through the process of starting and scaling your affiliate marketing business using the latest AI technology. Learn how to leverage ChatGPT to generate content ideas, create engaging articles, and connect with your audience through personalized interactions. From building your strategy and optimizing conversions to analyzing performance and staying updated with industry trends, this eBook provides everything you need to know to succeed in affiliate marketing. Whether you're a beginner looking to start your online business or an experienced marketer wanting to take your efforts to the next level, this guide is your roadmap to success in the world of affiliate marketing.
Boost Your Instagram Views Instantly Proven Free Strategies.pptx
Join Performance Car Exclusive to drive the finest supercars, engineered with advanced materials and cutting-edge technology for peak performance.
https://instblast.com/instagram/free-instagram-views
Amazing and On Point - Ramon Ray, USA TODAY
Amazing and On Point - Ramon Ray, USA TODAYDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Mastering The Best Restaurant Advertising Campaigns Detailed Guide
A guide for making the Best Restaurant Advertising Campaigns with demographics, data analytics, and digital advertising for measurable results.
Influencer Marketing Master Class - Alexis Andreasik
Influencer Marketing Master Class - Alexis AndreasikDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Empowering Influencers: The New Center of Brand-Consumer Dynamics
In the current market landscape, establishing genuine connections with consumers is crucial. This presentation, "Empowering Influencers: The New Center of Brand-Consumer Dynamics," explores how influencers have become pivotal in shaping brand-consumer relationships. We will examine the strategic use of influencers to create authentic, engaging narratives that resonate deeply with target audiences, driving success in the evolved purchase funnel.在线办理(英国UWS毕业证书)西苏格兰大学毕业证学位证一模一样
学校原件一模一样【微信：741003700 】《(英国UWS毕业证书)西苏格兰大学毕业证学位证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
AI Best Practices for Marketing HUG June 2024
During this presentation, the Nextiny marketing team reviews best practices when adopting generative AI into content creation. Join our HUG community to register for more events https://events.hubspot.com/sarasota/
Mastering SEO for Google in the AI Era - Dennis Yu
Mastering SEO for Google in the AI Era - Dennis YuDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Mastering Local SEO for Service Businesses in the AI Era"" is tailored specifically for local service providers like plumbers, dentists, and others seeking to dominate their local search landscape. This session delves into leveraging AI advancements to enhance your online visibility and search rankings through the Content Factory model, designed for creating high-impact, SEO-driven content. Discover the Dollar-a-Day advertising strategy, a cost-effective approach to boost your local SEO efforts and attract more customers with minimal investment. Gain practical insights on optimizing your online presence to meet the specific needs of local service seekers, ensuring your business not only appears but stands out in local searches. This concise, action-oriented workshop is your roadmap to navigating the complexities of digital marketing in the AI age, driving more leads, conversions, and ultimately, success for your local service business.
Key Takeaways:
Embrace AI for Local SEO: Learn to harness the power of AI technologies to optimize your website and content for local search. Understand the pivotal role AI plays in analyzing search trends and consumer behavior, enabling you to tailor your SEO strategies to meet the specific demands of your target local audience. Leverage the Content Factory Model: Discover the step-by-step process of creating SEO-optimized content at scale. This approach ensures a steady stream of high-quality content that engages local customers and boosts your search rankings. Get an action guide on implementing this model, complete with templates and scheduling strategies to maintain a consistent online presence. Maximize ROI with Dollar-a-Day Advertising: Dive into the cost-effective Dollar-a-Day advertising strategy that amplifies your visibility in local searches without breaking the bank. Learn how to strategically allocate your budget across platforms to target potential local customers effectively. The session includes an action guide on setting up, monitoring, and optimizing your ad campaigns to ensure maximum impact with minimal investment.Mastering Your Online Visibility - Fernando Angulo
Mastering Your Online Visibility - Fernando AnguloDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Unlock the secrets to enhancing your digital presence with our masterclass on mastering online visibility. Learn actionable strategies to boost your brand, optimize your social media, and leverage SEO. Transform your online footprint into a powerful tool for growth and engagement.
Key Takeaways:
1. Effective techniques to increase your brand's visibility across various online platforms.
2. Strategies for optimizing social media profiles and content to maximize reach and engagement.
3. Insights into leveraging SEO best practices to improve search engine rankings and drive organic traffic.Content Marketing Blueprint For Content Strategy, content creation, content d...
If you’re at all interested in digital
marketing and in making a name for
your brand online, then it is crucial that
you understand how to properly make
use of content marketing. Content
marketing is currently one of the
biggest trends in digital marketing as a
whole and is an area that many website owners and brands are investing in
heavily right now thanks to the impressive returns that they are seeing.
Embark on style journeys Indian clothing store denver guide.pptx
Finding the perfect "Indian Clothing Store Denver" is essential for those seeking vibrant, authentic, and culturally rich attire in the heart of Colorado. Denver, a city known for its diverse culture and eclectic fashion scene, offers a variety of options for those in search of traditional and contemporary Indian clothing. Whether you're preparing for a wedding, festival, or cultural event, or simply wish to incorporate the elegance and beauty of Indian fashion into your wardrobe, discovering the right store can make all the difference.
Breaking Silos To Break Bank: Shattering The Divide Between Search And Social
At Mozcon 2024 I shared this deck on bridging the divide between search and social. We began by acknowledging that search-first marketers are used to different rules of engagement than social marketers. We also looked at how both channels treat creative, audiences, bidding/budgeting, and AI. We finished by going through how they can win together including UTM audits, harvesting comments from both to inform creative, and allowing for non-login forums to be part of your marketing strategy.
I themed this deck using Baldur's Gate 3 characters: Gale as Search and Astarion as Social
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...DigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
Customer Experience is not only for B2C and big box brands. Embark on a transformative journey into the realm of B2B customer experience with our masterclass. In this dynamic session, we'll delve into the intricacies of designing and implementing seamless customer journeys that leave a lasting impression. Explore proven strategies and best practices tailored specifically for the B2B landscape, learning how to navigate complex decision-making processes and cultivate meaningful relationships with clients. From initial engagement to post-sale support, discover how to optimize every touchpoint to deliver exceptional experiences that drive loyalty and revenue growth. Join us and unlock the keys to unparalleled success in the B2B arena.
Key Takeaways:
1. Identify your customer journey and growth areas
2. Build a three-step customer experience strategy
3. Put your CX data to use and drive action in your organizationStory Telling Master Class - Jennifer Morilla
Story Telling Master Class - Jennifer MorillaDigiMarCon - Digital Marketing, Media and Advertising Conferences & Exhibitions
The Strategic Impact of Storytelling in the Age of AI
In the grand tapestry of marketing, where algorithms analyze data and artificial intelligence predicts trends, one essential thread remains constant — the timeless art of storytelling. As we stand on the precipice of a new era driven by AI, join me in unraveling the narrative alchemy that transforms brands from mere entities into captivating tales that resonate across the digital landscape. In this exploration, we will discover how, in the face of advancing technology, the human touch of a well-crafted story becomes not just a marketing tool but the very essence that breathes life into brands and forges lasting connections with our audience.Recently uploaded (20)
From Hope to Despair The Top 10 Reasons Businesses Ditch SEO Tactics.pptx
From Hope to Despair The Top 10 Reasons Businesses Ditch SEO Tactics.pptx
How to Kickstart Content Marketing With A Small Team - Dennis Shiao
How to Kickstart Content Marketing With A Small Team - Dennis Shiao
SEO in the AI Era - Trust, Quality and Content Discovery - Andy Crestodina
SEO in the AI Era - Trust, Quality and Content Discovery - Andy Crestodina
How to Start Affiliate Marketing with ChatGPT- A Step-by-Step Guide (1).pdf
How to Start Affiliate Marketing with ChatGPT- A Step-by-Step Guide (1).pdf
Boost Your Instagram Views Instantly Proven Free Strategies.pptx
Boost Your Instagram Views Instantly Proven Free Strategies.pptx
Mastering The Best Restaurant Advertising Campaigns Detailed Guide
Mastering The Best Restaurant Advertising Campaigns Detailed Guide
Influencer Marketing Master Class - Alexis Andreasik
Influencer Marketing Master Class - Alexis Andreasik
Mastering SEO for Google in the AI Era - Dennis Yu
Mastering SEO for Google in the AI Era - Dennis Yu
Mastering Your Online Visibility - Fernando Angulo
Mastering Your Online Visibility - Fernando Angulo
Content Marketing Blueprint For Content Strategy, content creation, content d...
Content Marketing Blueprint For Content Strategy, content creation, content d...
Embark on style journeys Indian clothing store denver guide.pptx
Embark on style journeys Indian clothing store denver guide.pptx
Breaking Silos To Break Bank: Shattering The Divide Between Search And Social
Breaking Silos To Break Bank: Shattering The Divide Between Search And Social
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...
Crafting Seamless B2B Customer Journeys - Strategies for Exceptional Experien...
Bangladesh pharma market
- 1. Prepared by: Biplob Kumar Sarker, B. Pharm, M. Pharm
- 2. Top Global Pharmaceutical Companies Here is the list of top 10 best pharmaceutical companies in 2014 that are renowned for their work in all over the world. 1. Pfizer 2. Novartis 3. Hoffmann-La Roche 4. Johnson & Johnson 5. Merck & Co 6. GlaxoSmithKline
- 3. Cont… 7. Sanofi 8. Eli Lilly 9. AstraZeneca 10. Abbott Laboratories
- 4. Highlights of Global Pharmaceutical Market The global pharmaceutical market will reach nearly USD 1200 million by 2016. The revenues from generics in 2016 are expected to reach USD 400–430 billion, approximately 70% of which will be outside developed markets.
- 5. Cont… Global generic spending is expected to increase from USD 242 billion to USD 400–430 billion by 2016, of which USD 224–244 billion of the increase is from low-cost generics in emerging markets. Global brand spending is forecast to increase from USD 596 billion in 2011 to USD 615–645 billion in 2016.
- 6. Cont… In addition, the highest growth in this market is observed in Asia-Pacific. Leading emerging countries will account for 28% of global spending on pharmaceuticals by 2015, compared to 12% in 2005. Over the next five years growth rate for emerging markets - 15 % to 20%, for matured markets – 6% to 10%
- 7. Cont… Blockbuster drugs ($150 billion) to lose patents between 2010 and 2017. Cardiovascular and CNS are the two largest market segments, constituting nearly 38% of the global generic pharmaceutical market together. However, therapeutic segments such as Respiratory, CNS and Oncology are likely to witness significantly high growth rates, attracting the attention of market participants.
- 8. Cont… On the contrary, segments such as Diabetes and Genitourinary/ hormonal drugs are expected to decline by the 2017.
- 9. History of Pharmaceutical Industry , Bangladesh In 2000, there were 210 licensed allopathic drug- manufacturing units in the country, out of which only 173 were in active production; others were either closed down on their own or suspended by the licensing authority for drugs due to non-compliance to good manufacturing practices or drug laws.
- 10. Cont… Now about 300 pharmaceutical companies are operating at the moment. The industry manufactured about 5,600 brands of medicines in different dosage forms. There were, however, 1,495 wholesale drug license holders and about 37,700 retail drug license holders in Bangladesh.
- 11. Cont… The pharmaceutical sector is one of the thrust sectors in Bangladesh. Before Liberation, there was hardly any pharmaceutical enterprise in Bangladesh (then East Pakistan). After several years of liberation, the government could not increase (in relative terms) budgetary allocations for the improvement of health sector. This sector started to improve from 1980s.
- 12. Establishment Year of Various Pharmaceuticals Company of BD Sl. Name of the Company Establishment Date 1 Square Pharmaceuticals Ltd. 1958 2 Incepta Pharmaceuticals Ltd. 1999 3 Beximco Pharma Ltd. 1976 4 The ACME Laboratories Ltd. 1954 5 Opsonin Pharma Ltd. 1956 6 ESKAYEF Bangladesh Ltd. 1979 6 Aristopharma Ltd. 1986 7 ACI Ltd. 1968 8 The ACME Laboratories Ltd 1954 9 Drug International Limited 1974 10 Healthcare Pharmaceuticals limited 1988
- 13. Cont… Sl. Name of the Company Establishment Date 11 GENERAL Pharmaceuticals Ltd. 1984 12 Popular Pharmaceuticals Ltd. 2002 13 RADIANT Pharmaceuticals Ltd. 2004 14 ORION Pharma Ltd. 1965 15 Unimed & Unihealth Ltd. 1972 16 IBN SINA Pharmaceutical Ltd. 1983 17 Nuvista Pharma Limited 1964 18 Globe Pharmaceuticals Ltd. 1986 19 Beacon Pharmaceuticals Ltd. 2001 20 PACIFIC Pharmaceuticals Ltd. 1990
- 14. Present Situation Of BD Pharma Market Bangladesh has emerged rapidly during the last 10 years. The infrastructure has developed during this period. Bangladesh has achieved tremendous success in pharmaceutical sector as well. Pharmaceutical industry is using state-of-the-art manufacturing technology and highly skilled human resources.
- 15. Cont… This industry is the fastest growing sector in Bangladesh. The domestic market size is US$1. 136 billion with a growth rate of 23.59 per cent in 2011. During the last several years, this sector is having significant growth. Within next 4-5 years, the expected market size of Bangladesh would be around US$ 3.0 billion per year.